41.82
1.25%
-0.53
Pre-mercato:
41.50
-0.32
-0.77%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$42.35
Aprire:
$42.29
Volume 24 ore:
1.12M
Relative Volume:
0.67
Capitalizzazione di mercato:
$7.76B
Reddito:
$493.63M
Utile/perdita netta:
$160.55M
Rapporto P/E:
76.04
EPS:
0.55
Flusso di cassa netto:
$162.20M
1 W Prestazione:
+0.97%
1M Prestazione:
-4.59%
6M Prestazione:
+73.60%
1 anno Prestazione:
+90.78%
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SAN FRANCISCO
Doximity Inc Stock (DOCS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-01-03 | Iniziato | Barclays | Equal Weight |
2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
2023-08-09 | Downgrade | Needham | Buy → Hold |
2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2022-10-31 | Iniziato | Wells Fargo | Overweight |
2022-10-24 | Iniziato | Evercore ISI | In-line |
2022-10-13 | Iniziato | BTIG Research | Neutral |
2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2022-09-07 | Iniziato | Truist | Hold |
2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
2022-07-28 | Iniziato | Berenberg | Buy |
2022-05-18 | Reiterato | BofA Securities | Neutral |
2022-05-18 | Reiterato | Goldman | Buy |
2022-05-18 | Reiterato | Guggenheim | Buy |
2022-05-18 | Reiterato | Jefferies | Buy |
2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
2022-05-18 | Reiterato | Needham | Buy |
2022-04-07 | Iniziato | Guggenheim | Buy |
2022-04-04 | Iniziato | BofA Securities | Neutral |
2022-02-11 | Iniziato | Goldman | Buy |
2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
2021-12-02 | Iniziato | Jefferies | Buy |
2021-11-17 | Iniziato | Robert W. Baird | Outperform |
2021-11-10 | Reiterato | Canaccord Genuity | Buy |
2021-11-10 | Reiterato | Goldman | Neutral |
2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
2021-11-10 | Reiterato | Needham | Buy |
2021-11-10 | Reiterato | Piper Sandler | Overweight |
2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
2021-07-19 | Iniziato | Canaccord Genuity | Buy |
2021-07-19 | Iniziato | Goldman | Neutral |
2021-07-19 | Iniziato | JP Morgan | Overweight |
2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
2021-07-19 | Iniziato | Piper Sandler | Overweight |
2021-07-19 | Iniziato | Raymond James | Outperform |
2021-07-19 | Iniziato | SVB Leerink | Outperform |
2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
Doximity director Kira Wampler sells $105,000 in stock - Investing.com
Doximity director Timothy Cabral sells $841,306 in stock - Investing.com
Rice Hall James & Associates LLC Decreases Stock Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity to Present at the Jefferies London Healthcare Conference - StockTitan
Doximity (DOCS) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
Doximity (NASDAQ:DOCS) Stock Price Expected to Rise, Morgan Stanley Analyst Says - MarketBeat
Twin Peaks Wealth Advisors LLC Invests $872,000 in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (DOCS) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Doximity's SWOT analysis: stock poised for growth amid market shifts - Investing.com
Doximity (DOCS) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Friedenthal Financial Acquires New Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Zacks Industry Outlook Highlights Elevance Health, Doximity and HealthEquity - Yahoo Finance
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Swedbank AB - MarketBeat
Vertical Software Stocks Q2 Teardown: Doximity (NYSE:DOCS) Vs The Rest - Yahoo Finance
Unity Software Inc (U-N) QuotePress Release - The Globe and Mail
Doximity to Release Fiscal 2025 Second Quarter Results on November 7, 2024 - Post Register
3 Medical Services Stocks to Buy to Navigate Industry Challenges - Benzinga
Are Medical Stocks Lagging Atea Pharmaceuticals (AVIR) This Year? - Yahoo Finance
Analyst upgrades Doximity shares to Overweight, pointing to end market stabilization and growth inflection - Investing.com India
Doximity (NASDAQ:DOCS) Shares Gap UpHere's What Happened - MarketBeat
Doximity (NASDAQ:DOCS) Raised to Overweight at Barclays - MarketBeat
Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued? - Simply Wall St
Top 10 Digital Health Companies | Provides Best Online SupportMarket.us Media - Market.us Media - United States Market News
AQR Capital Management LLC Reduces Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Doximity, Inc. (DOCS): A Bull Case Theory - Yahoo Finance
Millennium Management LLC Has $6.19 Million Stock Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity Inc (DOCS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Evercore ISI Boosts Doximity (NASDAQ:DOCS) Price Target to $45.00 - MarketBeat
Doximity price target raised to $45 from $32 at BofA - Yahoo Finance
BofA sees upside for Doximity stock amid inflecting pharma ad spend - Investing.com Australia
DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.’s Directors and Officers for Breach of Fiduciary Duties – DOCS - Business Wire
Evaluating Doximity: Insights From 11 Financial Analysts - Benzinga
Doximity (NASDAQ:DOCS) Sets New 12-Month High After Analyst Upgrade - Defense World
Bank of America Raises Doximity (NASDAQ:DOCS) Price Target to $45.00 - MarketBeat
BofA sees upside for Doximity stock amid inflecting pharma ad spend By Investing.com - Investing.com South Africa
Sei Investments Co. Purchases 16,803 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Dr. Scott Kamelle Achieves Prestigious Milestone with Over 700 Citations on Doximity, Establishing Himself in the Top 10% of the H-Index among Medical Professionals - Barchart
Dr. Scott Kamelle Recognized for Outstanding Research Contributions: Surpasses 700 Citations on Doximity, Placing Him in the Top 10% of the h-index Community - Yahoo
Doximity: Downgrade To Hold On Valuation Concerns - Seeking Alpha
Alternative Investment Advisors LLC. Purchases Shares of 13,046 Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity director Kira Scherer sells $108,600 in company stock - Investing.com India
Doximity director Kira Scherer sells $108,600 in company stock By Investing.com - Investing.com South Africa
Cim LLC Invests $1.96 Million in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Envestnet Asset Management Inc. Purchases 21,005 Shares of Doximity, Inc. (NASDAQ:DOCS) - Defense World
Doximity (NASDAQ:DOCS) Hits New 12-Month High at $43.91 - MarketBeat
Doximity stock soars to 52-week high of $43.58 amid robust growth - Investing.com
Doximity stock soars to 52-week high of $43.58 amid robust growth By Investing.com - Investing.com South Africa
Why Doximity Shares Are Trading Higher Today - MSN
Axa S.A. Boosts Stock Position in Doximity, Inc. (NASDAQ:DOCS) - Defense World
Capital Investments At Doximity (NYSE:DOCS) Point To A Promising Future - Yahoo Finance
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):